<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Gastrointestinal endoscopy in adults: Procedural sedation administered by endoscopists
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Gastrointestinal endoscopy in adults: Procedural sedation administered by endoscopists
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Gastrointestinal endoscopy in adults: Procedural sedation administered by endoscopists
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jonathan Cohen, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John R Saltzman, MD, FACP, FACG, FASGE, AGAF
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Girish P Joshi, MB, BS, MD, FFARCSI
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kristen M Robson, MD, MBA, FACG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Mar 28, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Research and development in the field of gastrointestinal (GI) endoscopy has greatly expanded the diagnostic and therapeutic capabilities of these procedures. Adequate patient tolerance is essential for the successful completion of a safe examination and compliance with subsequent follow-up. As a result, endoscopists have developed skills in administering procedural sedation to facilitate procedures and enhance patient comfort.
        </p>
        <p>
         This topic will discuss the endoscopist's approach to procedural sedation for GI endoscopy in adults. Anesthetic management for GI endoscopy delivered by anesthesia clinicians, including the use of
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         , deep sedation, and general anesthesia, is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/105511.html" rel="external">
          "Anesthesia for gastrointestinal endoscopy in adults"
         </a>
         .)
        </p>
        <p>
         Adverse events related to sedation for GI endoscopy are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2599.html" rel="external">
          "Adverse events related to procedural sedation for gastrointestinal endoscopy in adults"
         </a>
         .)
        </p>
        <p>
         Some patients may not require or may not want to have intravenous sedation. The approach to performing GI endoscopy without sedation is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2569.html" rel="external">
          "Sedation-free gastrointestinal endoscopy"
         </a>
         .)
        </p>
        <p>
         Our approach to procedural sedation for patients undergoing GI endoscopy is generally consistent with guidelines from the American Society of Gastrointestinal Endoscopy (ASGE) [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H171851976">
         <span class="h1">
          GENERAL PRINCIPLES
         </span>
        </p>
        <p class="headingAnchor" id="H1300876173">
         <span class="h2">
          Levels of sedation
         </span>
         <span class="headingEndMark">
          —
         </span>
         A sedation continuum has been described, ranging from minimal sedation (anxiolysis) to general anesthesia  (
         <a class="graphic graphic_table graphicRef109909" href="/z/d/graphic/109909.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/94529.html" rel="external">
          "Monitored anesthesia care in adults", section on 'Clinical assessment of sedation'
         </a>
         .)
        </p>
        <p>
         Moderate sedation (previously referred to as conscious sedation) is defined as a drug-induced depression of consciousness during which patients respond purposefully to verbal commands, either alone or accompanied by light tactile stimulation [
         <a href="#rid2">
          2
         </a>
         ]. No interventions are required to maintain a patent airway when spontaneous ventilation is maintained. In contrast, a deeply sedated patient may respond to a painful stimulus but otherwise cannot be aroused easily.
        </p>
        <p>
         Minimal sedation (anxiolysis) or moderate sedation is appropriate for most nonadvanced endoscopic procedures (eg, diagnostic upper endoscopy, screening colonoscopy). However, it is not always possible to predict how a patient will respond to sedation, and continuous monitoring is required to detect and address hemodynamic changes before a significant cardiorespiratory event occurs. (See
         <a class="local">
          'Monitoring'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1268809445">
         <span class="h2">
          Goals
         </span>
         <span class="headingEndMark">
          —
         </span>
         Goals of procedural sedation for GI endoscopy are to relieve patient anxiety and pain, improve the outcome of the examination, and diminish the patient's memory of the event [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1660190416">
         <span class="h2">
          Clinical use and requirements
         </span>
         <span class="headingEndMark">
          —
         </span>
         Minimal or moderate sedation is commonly administered by endoscopists during nonadvanced endoscopic procedures (eg, upper endoscopy, colonoscopy) for patients who are American Society of Anesthesiologists (ASA) physical status ≤III. The ASA physical status classification system is a system for stratifying periprocedural risk of morbidity and mortality for patient-specific risk factors. (See
         <a class="local">
          'American Society of Anesthesiologists physical status'
         </a>
         below.)
        </p>
        <p>
         Endoscopic procedures may be performed in several settings (free standing endoscopy unit, in-hospital endoscopy unit, other in-hospital locations outside of the endoscopy unit [eg, intensive care unit, operating room]). Basic and emergency equipment (eg, oral suction devices, oral airways, ventilatory devices such as Ambu bag), medications (including reversal agents), and personnel (including those trained in resuscitating a sedated patient) should be the same, regardless of the location. (See
         <a class="medical medical_review" href="/z/d/html/91909.html" rel="external">
          "Office-based anesthesia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3407483962">
         <span class="h2">
          Anesthesiology consultation
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients who will have GI endoscopy with sedation, consultation with an anesthesia clinician to administer sedation is generally obtained for the following (see
         <a class="local">
          'Presedation evaluation'
         </a>
         below):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patient characteristics:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         ASA physical status classification ≥IV (ie, severe comorbid illness)  (
         <a class="graphic graphic_table graphicRef87504" href="/z/d/graphic/87504.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'American Society of Anesthesiologists physical status'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of difficult intubation.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Potential difficult airway based on airway examination. (See
         <a class="local">
          'Focused physical examination'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of a hemodynamically significant adverse reaction to moderate sedation (eg, respiratory depression, hypoxemia).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of intolerance to procedures performed with moderate level of sedation.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of or active alcohol or substance use disorder.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Class III obesity (ie, body mass index [BMI] ≥40 kg/m
         <sup>
          2
         </sup>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Increased risk for airway obstruction (eg, anatomic variant, such as macroglossia, tonsillar hypertrophy, or nonvisible uvula; severe obstructive sleep apnea) [
         <a href="#rid2">
          2
         </a>
         ]. Patients who meet criteria for sleep apnea are traditionally classified based on symptoms and the apnea-hypopnea index, and this is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7706.html" rel="external">
          "Clinical presentation and diagnosis of obstructive sleep apnea in adults", section on 'Classification of severity'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Indication for urgent endoscopy (eg, patients with active GI bleeding and increased risk for aspiration).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Procedure-related characteristics:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Advanced and/or therapeutic procedure (eg, endoscopic retrograde cholangiopancreatography, endoscopic ultrasound). (See
         <a class="medical medical_review" href="/z/d/html/105511.html" rel="external">
          "Anesthesia for gastrointestinal endoscopy in adults", section on 'Advanced endoscopic procedures'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          PRESEDATION EVALUATION
         </span>
        </p>
        <p class="headingAnchor" id="H2050488981">
         <span class="h2">
          Goals
         </span>
         <span class="headingEndMark">
          —
         </span>
         A medical history is obtained and a focused physical examination is performed for all patients who receive sedation for endoscopy. The goals for presedation evaluation are to identify underlying conditions that may increase risk and to create a plan for procedural sedation that minimizes risk, while managing coexisting medical conditions.
        </p>
        <p class="headingAnchor" id="H2496523817">
         <span class="h2">
          Risk factors for adverse events
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patient characteristics that may increase risk for intolerance to sedative and anesthetic medications or for adverse events include [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Risk factors for intolerance to moderate sedation [
         <a href="#rid3">
          3
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of or active substance use disorder (eg, alcohol, opioids)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of anxiety disorder
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Chronic benzodiazepine use
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Chronic opioid use
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Use of an opioid agonist (eg,
         <a class="drug drug_general" data-topicid="9170" href="/z/d/drug information/9170.html" rel="external">
          buprenorphine
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of intolerance to procedures performed with moderate sedation
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Risk factors for difficult airway management:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Established or suspected obstructive sleep apnea (eg, periods of silence followed by loud snoring) (see
         <a class="medical medical_review" href="/z/d/html/7706.html" rel="external">
          "Clinical presentation and diagnosis of obstructive sleep apnea in adults"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Dysmorphic facial features (eg, trisomy 21)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Oral abnormalities (eg, small oral aperture [&lt;3 cm in adults], macroglossia, nonvisible uvula, edentulous mouth)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Neck abnormalities (eg, decreased hyoid-mental distance [&lt;3 cm in adults], neck mass, rheumatoid arthritis)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Class III obesity (ie, body mass index [BMI] ≥40 kg/m
         <sup>
          2
         </sup>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Risk factors for aspiration:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of gastroparesis
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Class III obesity (ie, BMI ≥40 kg/m
         <sup>
          2
         </sup>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ingestion of solid food &lt;6 hours prior to procedure
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ingestion of liquids &lt;2 hours prior to procedure
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Suspected bowel obstruction (eg, vomiting, abdominal pain, abdominal distension) (see
         <a class="medical medical_review" href="/z/d/html/8037.html" rel="external">
          "Etiologies, clinical manifestations, and diagnosis of mechanical small bowel obstruction in adults", section on 'Clinical presentations'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Inability to swallow solids and/or liquids, including secretions (see
         <a class="medical medical_review" href="/z/d/html/2241.html" rel="external">
          "Approach to the evaluation of dysphagia in adults", section on 'Acute dysphagia'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Acute upper GI bleeding (see
         <a class="medical medical_review" href="/z/d/html/2548.html" rel="external">
          "Approach to acute upper gastrointestinal bleeding in adults"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Large or tense ascites with abdominal distension (see
         <a class="medical medical_review" href="/z/d/html/1261.html" rel="external">
          "Evaluation of adults with ascites", section on 'Diagnosis'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other risk factors for adverse events:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Comorbid conditions (chronic lung, liver or kidney disease, coronary artery disease) [
         <a href="#rid4">
          4,5
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/91242.html" rel="external">
          "Anesthesia for the patient with liver disease"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Older adults (≥65 years of age) (see
         <a class="medical medical_review" href="/z/d/html/14931.html" rel="external">
          "Anesthesia for the older adult"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of adverse reaction to sedatives
        </p>
        <p>
        </p>
        <p>
         Anesthetic management options for patients with one or more risk factors for adverse events with intravenous sedation depends on the specific risk factor(s), clinician preferences, patient preferences, and the available resources. Management options for at-risk patients may include a sedation level goal of minimal sedation (rather than moderate), adjusting the sedative/analgesic regimen and/or dosing (eg, using
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         alone, using longer time intervals between doses), or consulting an anesthesia clinician. (See
         <a class="local">
          'Anesthesiology consultation'
         </a>
         above and
         <a class="local">
          'Sedation management'
         </a>
         below.)
        </p>
        <p>
         For some patients undergoing nonadvanced procedures (eg, diagnostic upper endoscopy), unsedated endoscopy is a reasonable alternative to intravenous sedation, and this is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2569.html" rel="external">
          "Sedation-free gastrointestinal endoscopy"
         </a>
         .)
        </p>
        <p>
         Airway management for patients at risk for respiratory depression or obstruction, including the use of airway devices, is presented separately. (See
         <a class="medical medical_review" href="/z/d/html/105511.html" rel="external">
          "Anesthesia for gastrointestinal endoscopy in adults", section on 'Airway management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4266549350">
         <span class="h2">
          Focused physical examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         Presedation focused physical examination includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Baseline level of consciousness
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vital signs, weight, height
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Heart and lung auscultation
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abdominal exam (ie, assess for distension, tenderness)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Airway assessment, including determination of the Mallampati classification  (
         <a class="graphic graphic_figure graphicRef75229" href="/z/d/graphic/75229.html" rel="external">
          figure 1
         </a>
         ), mouth opening &gt;3 fingerbreadths, neck mobility
        </p>
        <p>
        </p>
        <p>
         The Mallampati classification identifies patients at increased risk for difficult endotracheal intubation or sleep apnea, and it is a scoring system that relates the amount of mouth opening to the size of the tongue [
         <a href="#rid1">
          1
         </a>
         ]. Other physical features that could make positive pressure ventilation or endotracheal intubation difficult include obesity, decreased distance between the mentum and the neck/mandible junction (&lt;3 cm in adults), cervical spine disease (eg, rheumatoid arthritis), structural abnormalities of the mouth, and jaw or oral cavity  (
         <a class="graphic graphic_picture graphicRef60507" href="/z/d/graphic/60507.html" rel="external">
          picture 1
         </a>
         ). Clinical features predicting a difficult airway are discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/275.html" rel="external">
          "Approach to the difficult airway in adults for emergency medicine and critical care", section on 'Identifying the anatomically difficult airway'
         </a>
         .)
        </p>
        <p>
         No published data have shown that determining the Mallampati classification prior to endoscopy leads to reduced risk of cardiorespiratory adverse events. However, assigning Mallampati class may identify patients at increased risk for difficult airway management if they progress from moderate to deep sedation in which airway reflexes might be lost. (See
         <a class="local">
          'Anesthesiology consultation'
         </a>
         above and
         <a class="local">
          'Risk factors for adverse events'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H334341402">
         <span class="h2">
          American Society of Anesthesiologists physical status
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients are classified using the American Society of Anesthesiologists (ASA) physical status classification to identify patients who are at increased risk for periprocedural adverse events  (
         <a class="graphic graphic_table graphicRef87504" href="/z/d/graphic/87504.html" rel="external">
          table 2
         </a>
         ). For patients with increased risk of adverse events because of severe comorbid illness (ASA classification ≥IV), an anesthesia clinician is consulted to provide sedation. (See
         <a class="local">
          'Anesthesiology consultation'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H235981708">
         <span class="h2">
          Pregnancy
         </span>
         <span class="headingEndMark">
          —
         </span>
         For women of childbearing age who are uncertain of pregnancy status and are undergoing endoscopy with mild to moderate sedation, a preprocedure urine or serum pregnancy test is performed, unless the patient refuses and waives the testing in writing. For women who are pregnant, the approach to intravenous sedation is discussed below. (See
         <a class="local">
          'Special populations'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3905700095">
         <span class="h1">
          PREPROCEDURE PREPARATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Preprocedure preparation includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preoperative fasting
         </strong>
         – Patients should follow preoperative fasting guidelines as they would for any type of anesthetic  (
         <a class="graphic graphic_table graphicRef94641" href="/z/d/graphic/94641.html" rel="external">
          table 3
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/15698.html" rel="external">
          "Preoperative fasting in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Specifically, the American Society of Anesthesiologists (ASA) guidelines state that patients should fast for a minimum of two hours after ingestion of clear liquids and six hours after ingestion of light meals before sedation is administered.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Informed consent
         </strong>
         – Informed consent is obtained prior to all GI endoscopic procedures. Informed consent is a process that involves discussing the procedure (including administration of sedation) and the associated risks, benefits, alternatives, and limitations. (See
         <a class="medical medical_review" href="/z/d/html/15076.html" rel="external">
          "Informed procedural consent"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4150993338">
         <span class="h1">
          SEDATION MANAGEMENT
         </span>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Monitoring
         </span>
         <span class="headingEndMark">
          —
         </span>
         The goal of intraprocedural monitoring for patients undergoing endoscopic procedures is to detect changes in pulse, blood pressure, ventilatory status, cardiac electrical activity, and level of sedation so that they can be addressed before a significant cardiorespiratory adverse event occurs [
         <a href="#rid1">
          1
         </a>
         ]. During endoscopic procedures with mild to moderate sedation, the personnel responsible for patient monitoring can perform brief, interruptible tasks [
         <a href="#rid6">
          6
         </a>
         ]. (See
         <a class="local">
          'Levels of sedation'
         </a>
         above.)
        </p>
        <p>
         Monitoring is performed using a combination of visual assessment and monitoring devices:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         At a minimum, assessing level of consciousness and vital signs occurs [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Before the procedure is started
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         After administration of sedative-analgesic medications
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         At least every five minutes during the procedure
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         During initial recovery
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Immediately prior to discharge
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The approach to intraprocedural monitoring of hemodynamic and ventilatory status includes [
         <a href="#rid1">
          1,2,6,7
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hemodynamic monitoring – Heart rate is monitored continuously, and blood pressure is checked at baseline and then at three- to five-minute intervals.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Electrocardiography – We use continuous electrocardiographic monitoring for all patients. Society guidelines state that electrocardiographic monitoring is required for patients with a history of cardiovascular disease or cardiac dysrhythmia.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pulse oximetry – Continuous pulse oximetry is required for all patients [
         <a href="#rid8">
          8
         </a>
         ]. However, it is relatively insensitive for detecting early hypoventilation and is not a replacement for direct observation of the patient.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Capnography – Ventilation is often monitored noninvasively with capnography (carbon dioxide monitoring in exhaled breath) during moderate sedation. Society guidelines on the use of capnography during nonadvanced endoscopic procedures with moderate sedation vary in their recommendations [
         <a href="#rid1">
          1,2,6
         </a>
         ]; however, there is consensus that patients undergoing advanced endoscopic procedures (eg, endoscopic retrograde cholangiopancreatography, endoscopic ultrasound) are routinely monitored with capnography. The benefits of capnography include facilitating early detection of apnea and airway obstruction and predicting the development of hypoxemia, and this is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/105511.html" rel="external">
          "Anesthesia for gastrointestinal endoscopy in adults", section on 'Monitoring'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Capnography is typically obtained using a separate sample cannula that connects to the nasal cannula delivering supplemental oxygen. (See
         <a class="local">
          'Supplemental oxygen'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Alternatively, this cannula can be connected to or taped within a face mask. An infrared measuring cell analyzes the carbon dioxide content of inspired and expired gases. The data are displayed as a capnographic waveform, and capnography is discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/273.html" rel="external">
          "Carbon dioxide monitoring (capnography)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Supplemental oxygen
         </span>
         <span class="headingEndMark">
          —
         </span>
         Supplemental low-flow oxygen (eg, 3 liters per minute) is routinely provided for patients receiving intravenous sedation [
         <a href="#rid2">
          2
         </a>
         ]. Oxygen is typically administered via nasal cannula, while face mask is an alternative delivery method.
        </p>
        <p>
         Oxygen supplementation reduced the hypoxemia rate for patients undergoing GI endoscopy. In a trial of 389 patients receiving moderate sedation for endoscopic procedures, the rate of hypoxemia (oxygen desaturation ≤95 percent) was lower in patients given nasal cannula oxygen compared with no supplemental oxygen (12 versus 71 percent) [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
         Indirect data from studies of oxygen use during moderate sedation for patients in other settings (eg, emergency room) also support the routine use of supplemental oxygen [
         <a href="#rid10">
          10,11
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3012174256">
         <span class="h2">
          Sedatives and analgesics
         </span>
        </p>
        <p class="headingAnchor" id="H1774975153">
         <span class="h3">
          Choosing a drug regimen
         </span>
         <span class="headingEndMark">
          —
         </span>
         For most patients having an endoscopic procedure with minimal or moderate sedation administered by the endoscopist, the typical drug regimen is a combination of
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         (to minimize anxiety) and
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         (to minimize pain) [
         <a href="#rid1">
          1,12
         </a>
         ]. Midazolam alone is a reasonable alternative, particularly for patients who may have increased risk for adverse events related to sedatives and analgesics (eg, older adults) [
         <a href="#rid13">
          13
         </a>
         ]. (See
         <a class="local">
          'Risk factors for adverse events'
         </a>
         above.)
        </p>
        <p>
         The dose, onset, duration, and effects of drugs that are commonly used for sedation administered by nonanesthesia clinicians are shown in the table  (
         <a class="graphic graphic_table graphicRef65736" href="/z/d/graphic/65736.html" rel="external">
          table 4
         </a>
         ), and they are discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/105511.html" rel="external">
          "Anesthesia for gastrointestinal endoscopy in adults", section on 'Choice of drugs for sedation/analgesia'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h3">
          Midazolam
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          Midazolam
         </a>
         is a short-acting benzodiazepine with anxiolytic, amnestic, and sedative effects, but without analgesic effects. Midazolam potentiates the effects of other sedatives and opioids, and can cause respiratory depression when given in high doses or with other agents. (See
         <a class="medical medical_review" href="/z/d/html/94529.html" rel="external">
          "Monitored anesthesia care in adults", section on 'Midazolam'
         </a>
         .)
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          Midazolam
         </a>
         dosing and administration depends on patient age and comorbid conditions associated with increased sensitivity to sedation (see
         <a class="local">
          'Risk factors for adverse events'
         </a>
         above):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adults &lt;65 years of age and without comorbidities – For adults &lt;65 years of age and without comorbidities, the initial bolus dose of
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         is 1 to 2 mg over two to three minutes. If the initial dose does not result in anxiolysis or adequate sedation, additional 0.5 to 1 mg boluses can be given every two to five minutes to achieve the desired depth of sedation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adults ≥65 years of age and/or with comorbidities – For adults ≥65 years of age and/or with comorbidities, the initial bolus dose of
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         is 0.5 to 1 mg intravenously. If the initial dose does not result in anxiolysis or adequate sedation, subsequent doses (0.5 mg intravenously) can be given every two to five minutes.
        </p>
        <p>
        </p>
        <p>
         The onset of action of an intravenous bolus of
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         occurs in about one to three minutes, with peak effect at approximately five minutes. The elimination half-life of midazolam is one to four hours [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
         If
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         is used in combination with an opioid and additional drug doses are required during the procedure, only one drug is administered at a time for subsequent boluses. For example, we wait for two to five minutes following each midazolam dose to observe the effect before determining if an additional opioid dose is required. (See
         <a class="local">
          'Opioids'
         </a>
         below.)
        </p>
        <p>
         If the level of sedation exceeds moderate sedation, the effects of
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         can be temporarily reversed with
         <a class="drug drug_general" data-topicid="8456" href="/z/d/drug information/8456.html" rel="external">
          flumazenil
         </a>
         . The dosing and administration of flumazenil is listed in the table  (
         <a class="graphic graphic_table graphicRef106215" href="/z/d/graphic/106215.html" rel="external">
          table 5
         </a>
         ). (See
         <a class="local">
          'Levels of sedation'
         </a>
         above.)
        </p>
        <p>
         The use of reversal agents is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2599.html" rel="external">
          "Adverse events related to procedural sedation for gastrointestinal endoscopy in adults", section on 'Management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h3">
          Opioids
         </span>
         <span class="headingEndMark">
          —
         </span>
         Opioids are given during procedural sedation for GI endoscopy to provide analgesia.
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          Fentanyl
         </a>
         is most commonly used because of its rapid onset of action and clearance. Fentanyl is typically administered intravenously in small intermittent boluses of 25 or 50 mcg, with lower doses (ie, 12.5 or 25 mcg) for patients at risk for increased sensitivity to analgesics (eg, patients with cardiopulmonary disease, older patients). (See
         <a class="local">
          'Risk factors for adverse events'
         </a>
         above.)
        </p>
        <p>
         For
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         , the onset of action is two to three minutes, and the dose may be repeated in two minutes if the desired level of analgesia is not achieved  (
         <a class="graphic graphic_table graphicRef65736" href="/z/d/graphic/65736.html" rel="external">
          table 4
         </a>
         ).
        </p>
        <p>
         If
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         is being used in combination with
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         and additional drug doses are required during the procedure, only one drug is administered at a time for subsequent boluses. For example, we wait for two minutes following each fentanyl dose to observe the effect before determining if an additional midazolam dose is required. (See
         <a class="local">
          'Midazolam'
         </a>
         above.)
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9608" href="/z/d/drug information/9608.html" rel="external">
          Meperidine
         </a>
         is an opioid alternative to
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         . However, meperidine is rarely used and has been associated with longer recovery time and more adverse effects (eg, nausea) than fentanyl [
         <a href="#rid7">
          7
         </a>
         ]. In a trial including 111 patients undergoing upper endoscopy or colonoscopy, the total time (intraprocedure and recovery time) was longer for patients receiving meperidine compared with fentanyl (103 versus 88 minutes) [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p>
         In addition,
         <a class="drug drug_general" data-topicid="9608" href="/z/d/drug information/9608.html" rel="external">
          meperidine
         </a>
         is
         <strong>
          avoided
         </strong>
         in the following patients:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients taking monoamine oxidase inhibitors due to drug interactions. (See
         <a class="medical medical_review" href="/z/d/html/1715.html" rel="external">
          "Monoamine oxidase inhibitors (MAOIs): Pharmacology, administration, safety, and side effects"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with cirrhosis.
         <a class="drug drug_general" data-topicid="9608" href="/z/d/drug information/9608.html" rel="external">
          Meperidine
         </a>
         is metabolized extensively in the liver, and its clearance is reduced by liver dysfunction. (See
         <a class="medical medical_review" href="/z/d/html/1236.html" rel="external">
          "Management of pain in patients with advanced chronic liver disease or cirrhosis", section on 'Opioids'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          Fentanyl
         </a>
         should be used cautiously with lower initial and subsequent doses (ie, doses of 12.5 or 25 mcg) for patients with a history of seizures because opioids lower the seizure threshold. Periprocedural care of the patient with a seizure disorder is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4827.html" rel="external">
          "Perioperative care of the surgical patient with neurologic disease", section on 'Seizure disorders'
         </a>
         .)
        </p>
        <p>
         Opioids can be temporarily reversed with
         <a class="drug drug_general" data-topicid="9678" href="/z/d/drug information/9678.html" rel="external">
          naloxone
         </a>
         , although naloxone can induce acute opioid withdrawal in patients with a history of chronic opioid use  (
         <a class="graphic graphic_table graphicRef106215" href="/z/d/graphic/106215.html" rel="external">
          table 5
         </a>
         ). In addition, it may cause a significant increase in sympathetic activity, leading to hypertension and pulmonary edema. Reversal agents are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2599.html" rel="external">
          "Adverse events related to procedural sedation for gastrointestinal endoscopy in adults", section on 'Management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1634202023">
         <span class="h2">
          Topical anesthesia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Topical (pharyngeal) anesthesia can be administered prior to upper GI endoscopy to suppress the gag reflex, facilitate insertion of the endoscope, and possibly reduce the doses of intravenous drugs for sedation. While we do not routinely use pharyngeal anesthesia, it may be useful for patients having minimal or no procedural sedation or for patients who report gagging easily.
        </p>
        <p>
         Commonly used drugs for topical anesthesia include
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         and
         <a class="drug drug_general" data-topicid="9092" href="/z/d/drug information/9092.html" rel="external">
          benzocaine
         </a>
         , which are administered by aerosol spray or gargling. The effects last for up to one hour.
        </p>
        <p>
         Whether pharyngeal anesthesia resulted in less discomfort for patients given moderate procedural sedation is uncertain. In a meta-analysis of five trials including 491 patients undergoing upper endoscopy, patients given pharyngeal anesthesia were more likely to report no or minimal discomfort compared with no pharyngeal anesthesia (odds ratio [OR] 1.88, 95% CI 1.13-3.12), [
         <a href="#rid16">
          16
         </a>
         ]. However, indirect data suggested that for patients undergoing upper endoscopy with intravenous
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         , differences in verbal or somatic responses or gag reflex were not observed in those given pharyngeal anesthesia compared with placebo [
         <a href="#rid17">
          17,18
         </a>
         ].
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9092" href="/z/d/drug information/9092.html" rel="external">
          Benzocaine
         </a>
         has been associated with methemoglobinemia and should be
         <strong>
          avoided
         </strong>
         in patients with a previous history of methemoglobinemia or known glucose-6-phosphate dehydrogenase deficiency. (See
         <a class="medical medical_review" href="/z/d/html/7094.html" rel="external">
          "Methemoglobinemia", section on 'Topical anesthetics'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1114330049">
         <span class="h2">
          Pharmacologic adjuncts
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pharmacologic adjuncts to the combination of
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         and an opioid include
         <a class="drug drug_general" data-topicid="9369" href="/z/d/drug information/9369.html" rel="external">
          diphenhydramine
         </a>
         , which can potentiate the action of the drug regimen and prolong recovery time [
         <a href="#rid1">
          1
         </a>
         ]. Diphenhydramine is not used routinely, but it may be given to selected patients who are not expected to achieve moderate sedation with a midazolam-opioid regimen (eg, patients who use benzodiazepines or opioids chronically).
        </p>
        <p>
         When used as an adjunct,
         <a class="drug drug_general" data-topicid="9369" href="/z/d/drug information/9369.html" rel="external">
          diphenhydramine
         </a>
         , 25 to 50 mg intravenously, is typically given prior to initiating procedural sedation.
        </p>
        <p>
         Adverse effects associated with
         <a class="drug drug_general" data-topicid="9369" href="/z/d/drug information/9369.html" rel="external">
          diphenhydramine
         </a>
         include dizziness, blurred vision, dry mouth, epigastric discomfort, thickening of bronchial secretions, and urinary retention. Warnings/contraindications include narrow angle glaucoma and symptomatic prostatic hypertrophy. Respiratory depression is a concern with combinations of diphenhydramine and a benzodiazepine and/or opioid, particularly in at-risk patients (eg, those who are obese or have obstructive sleep apnea). (See
         <a class="local">
          'Presedation evaluation'
         </a>
         above.)
        </p>
        <p>
         Limited data on
         <a class="drug drug_general" data-topicid="9369" href="/z/d/drug information/9369.html" rel="external">
          diphenhydramine
         </a>
         use for GI endoscopy suggested that it improved sedation quality for some patients [
         <a href="#rid19">
          19,20
         </a>
         ]. In a trial of 119 patients on chronic opioid therapy, diphenhydramine plus
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         and
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         resulted in lower patient-reported pain scores compared with midazolam-fentanyl regimen alone [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
         The use of monitored anesthesia care and
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         for patients who do not achieve moderate sedation with a midazolam-opioid regimen is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/105511.html" rel="external">
          "Anesthesia for gastrointestinal endoscopy in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H215087654">
         <span class="h1">
          ADVERSE EVENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mild to moderate procedural sedation for GI endoscopy is generally well tolerated, but adverse events (eg, respiratory depression) can occur. These issues are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2599.html" rel="external">
          "Adverse events related to procedural sedation for gastrointestinal endoscopy in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3800636247">
         <span class="h1">
          POSTPROCEDURE CARE
         </span>
         <span class="headingEndMark">
          —
         </span>
         The pharmacologic effects of drugs used for sedation/analgesia usually extend beyond the duration of the endoscopic procedure. Monitoring (ie, vital signs, respiratory effort, and level of consciousness) and supplemental oxygen are maintained while the patient recovers from the effects of the medications. Patient care is transferred to recovery area personnel who can promptly detect respiratory or cardiovascular compromise. (See
         <a class="local">
          'Monitoring'
         </a>
         above.)
        </p>
        <p>
         Management of adverse events related to procedural sedation including postprocedure care for patients who required a reversal agent is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2599.html" rel="external">
          "Adverse events related to procedural sedation for gastrointestinal endoscopy in adults"
         </a>
         .)
        </p>
        <p>
         Patients who have completely recovered (ie, breathing spontaneously without need for any form of airway support, alert, speaking, responding appropriately to commands, and hemodynamically stable) can be prepared for discharge. Such patients are instructed to avoid driving a motor vehicle, operating machinery, or consuming alcohol until the following day. Patients are then discharged with an adult to accompany them home. Written instructions are also provided.
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          SPECIAL POPULATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H2262942364">
         <span class="h2">
          Pregnancy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some pregnant women require endoscopic evaluation when it is clear that failure to do so would expose the fetus and/or mother to harm [
         <a href="#rid21">
          21
         </a>
         ]. However, safety data on procedural sedation are based on small and uncontrolled retrospective studies, and potential adverse effects include teratogenicity [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
         Our approach to procedural sedation for pregnant women includes [
         <a href="#rid21">
          21-23
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Procedure timing – Endoscopic procedures are performed in the second trimester, whenever possible.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Obstetrics consultation – Obstetrics is consulted to assess the need for periprocedural fetal monitoring to ensure the viability of the pregnancy pre- and postprocedure.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Anesthetic management – For most pregnant women, we consult with an anesthesia clinician to provide procedural sedation (typically
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/6775.html" rel="external">
          "Anesthesia for nonobstetric surgery during pregnancy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For some pregnant women having nonadvanced endoscopic procedures, alternatives to sedation provided by an anesthesia clinician include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Unsedated endoscopy (with topical anesthetic for upper endoscopy) (see
         <a class="medical medical_review" href="/z/d/html/2569.html" rel="external">
          "Sedation-free gastrointestinal endoscopy"
         </a>
         ), or
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Minimal to moderate intravenous sedation (typically midazolam-fentanyl regimen) administered by the endoscopist [
         <a href="#rid24">
          24
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1153793626">
         <span class="h2">
          Lactation
         </span>
         <span class="headingEndMark">
          —
         </span>
         The approach to endoscopist-administered procedural sedation for women who are breastfeeding includes [
         <a href="#rid21">
          21
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/4996.html" rel="external">
          "Common problems of breastfeeding and weaning", section on 'Maternal use of medications'
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          Midazolam
         </a>
         – Infants should not be breastfed for at least four hours after maternal midazolam administration. After four hours, breast milk should be pumped and discarded before reinitiating breastfeeding. (See
         <a class="medical medical_review" href="/z/d/html/1720.html" rel="external">
          "Safety of infant exposure to antidepressants and benzodiazepines through breastfeeding", section on 'Benzodiazepines'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Opioids –
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          Fentanyl
         </a>
         is preferred for lactating women rather than
         <a class="drug drug_general" data-topicid="9608" href="/z/d/drug information/9608.html" rel="external">
          meperidine
         </a>
         because the concentrations of fentanyl in breast milk are too low to be pharmacologically significant, as opposed to meperidine, which is concentrated in breast milk [
         <a href="#rid25">
          25
         </a>
         ]. Breastfeeding may be continued without interruption after maternal fentanyl administration.
        </p>
        <p>
        </p>
        <p>
         The drugs and lactation database (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK501922%2F&amp;token=wEsKVFvqlKzpT%2BqOtddW%2Fy3%2BLj0shalBW%2BL1ZyL4trystKLNkAhaR%2FcduMJFFebszM73aaFBm717nqYa%2FpVDsg%3D%3D&amp;TOPIC_ID=2567" target="_blank">
          Lactmed
         </a>
         ), produced by the National Library of Medicine, is an online reference for lactation compatibility for drugs [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2185157731">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/120175.html" rel="external">
          "Society guideline links: Endoscopy preparation, sedation, and special considerations"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H592168016">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword[s] of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/15413.html" rel="external">
          "Patient education: Colonoscopy (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/2002.html" rel="external">
          "Patient education: Colonoscopy (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Minimal or moderate sedation is appropriate for most nonadvanced endoscopic procedures (eg, diagnostic upper endoscopy, screening colonoscopy). The goals of procedural sedation for gastrointestinal (GI) endoscopy are to relieve patient anxiety and pain, improve the outcome of the examination, and diminish the patient's memory of the event. (See
         <a class="local">
          'General principles'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For all patients undergoing GI endoscopy, a medical history is obtained and a focused physical examination is performed prior to giving intravenous sedation. The goals for presedation evaluation are to identify underlying conditions that may increase risk and to create a plan for procedural sedation that minimizes risk, while managing coexisting medical conditions. (See
         <a class="local">
          'Goals'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Consultation with an anesthesia clinician to administer sedation for GI endoscopy is generally obtained for any of the following patient or procedure characteristics (see
         <a class="local">
          'Anesthesiology consultation'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         American Society of Anesthesiologists (ASA) physical status classification ≥IV
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of difficult intubation
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Potential difficult airway based on airway examination (see
         <a class="local">
          'Focused physical examination'
         </a>
         above)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of a hemodynamically significant adverse reaction to sedation (eg, hypoxemia)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of intolerance to procedures performed with moderate level of sedation
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of or active alcohol or substance abuse
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Class III obesity (ie, body mass index [BMI] ≥40 kg/m
         <sup>
          2
         </sup>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Increased risk for airway obstruction (eg, severe obstructive sleep apnea)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Indication for urgent endoscopy (eg, patients with active GI bleeding and increased risk for aspiration)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Advanced and/or therapeutic procedure (eg, endoscopic retrograde cholangiopancreatography, endoscopic ultrasound)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients undergoing endoscopic procedures with intravenous sedation, monitoring includes visual assessment, hemodynamic monitoring (eg, heart rate, blood pressure), pulse oximetry, and often capnography. The goal of monitoring is to detect changes in pulse, blood pressure, ventilatory status, cardiac electrical activity, and level of sedation so that they can be addressed before a significant cardiorespiratory adverse event occurs. (See
         <a class="local">
          'Monitoring'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients having an endoscopic procedure with minimal or moderate sedation administered by the endoscopist, the typical drug regimen is a combination of
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         (to minimize anxiety) and
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         (to minimize pain)  (
         <a class="graphic graphic_table graphicRef65736" href="/z/d/graphic/65736.html" rel="external">
          table 4
         </a>
         ). (See
         <a class="local">
          'Sedatives and analgesics'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Procedural sedation for GI endoscopy is generally well tolerated but adverse events (eg, respiratory depression) can occur. These issues are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2599.html" rel="external">
          "Adverse events related to procedural sedation for gastrointestinal endoscopy in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The pharmacologic effects of drugs used for sedation/analgesia usually extend beyond the duration of the endoscopic procedure. Monitoring and supplemental oxygen are maintained while the patient recovers from the effects of the medications. Patients who have completely recovered (ie, breathing spontaneously without need for any form of airway support, alert, speaking, responding appropriately to commands, and hemodynamically stable) can be prepared for discharge. (See
         <a class="local">
          'Postprocedure care'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Anesthetic management for GI endoscopy administered by anesthesia clinicians, including the use of monitored anesthesia care,
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         , deep sedation, and general anesthesia, is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/105511.html" rel="external">
          "Anesthesia for gastrointestinal endoscopy in adults"
         </a>
         .)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           ASGE Standards of Practice Committee, Early DS, Lightdale JR, et al. Guidelines for sedation and anesthesia in GI endoscopy. Gastrointest Endosc 2018; 87:327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Practice Guidelines for Moderate Procedural Sedation and Analgesia 2018: A Report by the American Society of Anesthesiologists Task Force on Moderate Procedural Sedation and Analgesia, the American Association of Oral and Maxillofacial Surgeons, American College of Radiology, American Dental Association, American Society of Dentist Anesthesiologists, and Society of Interventional Radiology. Anesthesiology 2018; 128:437.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cha JM, Jeun JW, Pack KM, et al. Risk of sedation for diagnostic esophagogastroduodenoscopy in obstructive sleep apnea patients. World J Gastroenterol 2013; 19:4745.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vasudevan AE, Goh KL, Bulgiba AM. Impairment of psychomotor responses after conscious sedation in cirrhotic patients undergoing therapeutic upper GI endoscopy. Am J Gastroenterol 2002; 97:1717.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Assy N, Rosser BG, Grahame GR, Minuk GY. Risk of sedation for upper GI endoscopy exacerbating subclinical hepatic encephalopathy in patients with cirrhosis. Gastrointest Endosc 1999; 49:690.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ASGE Ensuring Safety in the Gastrointestinal Endoscopy Unit Task Force, Calderwood AH, Chapman FJ, et al. Guidelines for safety in the gastrointestinal endoscopy unit. Gastrointest Endosc 2014; 79:363.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           American Association for Study of Liver Diseases, American College of Gastroenterology, American Gastroenterological Association Institute, et al. Multisociety sedation curriculum for gastrointestinal endoscopy. Gastrointest Endosc 2012; 76:e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen LB, Delegge MH, Aisenberg J, et al. AGA Institute review of endoscopic sedation. Gastroenterology 2007; 133:675.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rozario L, Sloper D, Sheridan MJ. Supplemental oxygen during moderate sedation and the occurrence of clinically significant desaturation during endoscopic procedures. Gastroenterol Nurs 2008; 31:281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deitch K, Chudnofsky CR, Dominici P, et al. The utility of high-flow oxygen during emergency department procedural sedation and analgesia with propofol: a randomized, controlled trial. Ann Emerg Med 2011; 58:360.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deitch K, Chudnofsky CR, Dominici P. The utility of supplemental oxygen during emergency department procedural sedation and analgesia with midazolam and fentanyl: a randomized, controlled trial. Ann Emerg Med 2007; 49:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen LB, Wecsler JS, Gaetano JN, et al. Endoscopic sedation in the United States: results from a nationwide survey. Am J Gastroenterol 2006; 101:967.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barriga J, Sachdev MS, Royall L, et al. Sedation for upper endoscopy: comparison of midazolam versus fentanyl plus midazolam. South Med J 2008; 101:362.
          </a>
         </li>
         <li class="breakAll">
          https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=737361a0-8db1-4d3c-ba5e-44df3f49fa22 (Accessed on January 15, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robertson DJ, Jacobs DP, Mackenzie TA, et al. Clinical trial: a randomized, study comparing meperidine (pethidine) and fentanyl in adult gastrointestinal endoscopy. Aliment Pharmacol Ther 2009; 29:817.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Evans LT, Saberi S, Kim HM, et al. Pharyngeal anesthesia during sedated EGDs: is "the spray" beneficial? A meta-analysis and systematic review. Gastrointest Endosc 2006; 63:761.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de la Morena F, Santander C, Esteban C, et al. Usefulness of applying lidocaine in esophagogastroduodenoscopy performed under sedation with propofol. World J Gastrointest Endosc 2013; 5:231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsai HI, Tsai YF, Liou SC, et al. The questionable efficacy of topical pharyngeal anesthesia in combination with propofol sedation in gastroscopy. Dig Dis Sci 2012; 57:2519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tu RH, Grewall P, Leung JW, et al. Diphenhydramine as an adjunct to sedation for colonoscopy: a double-blind randomized, placebo-controlled study. Gastrointest Endosc 2006; 63:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nusrat S, Madhoun MF, Tierney WM. Use of diphenhydramine as an adjunctive sedative for colonoscopy in patients on chronic opioid therapy: a randomized controlled trial. Gastrointest Endosc 2018; 88:695.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ASGE Standard of Practice Committee, Shergill AK, Ben-Menachem T, et al. Guidelines for endoscopy in pregnant and lactating women. Gastrointest Endosc 2012; 76:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nguyen GC, Seow CH, Maxwell C, et al. The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. Gastroenterology 2016; 150:734.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van der Woude CJ, Ardizzone S, Bengtson MB, et al. The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. J Crohns Colitis 2015; 9:107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Igea F, Casellas JA, González-Huix F, et al. Sedation for gastrointestinal endoscopy. Clinical practice guidelines of the Sociedad Española de Endoscopia Digestiva. Rev Esp Enferm Dig 2014; 106:195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kronenfeld N, Berlin M, Shaniv D, Berkovitch M. Use of Psychotropic Medications in Breastfeeding Women. Birth Defects Res 2017; 109:957.
          </a>
         </li>
         <li class="breakAll">
          https://www.ncbi.nlm.nih.gov/books/NBK501922/ (Accessed on January 16, 2020).
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 2567 Version 26.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29306520" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Guidelines for sedation and anesthesia in GI endoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29334501" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Practice Guidelines for Moderate Procedural Sedation and Analgesia 2018: A Report by the American Society of Anesthesiologists Task Force on Moderate Procedural Sedation and Analgesia, the American Association of Oral and Maxillofacial Surgeons, American College of Radiology, American Dental Association, American Society of Dentist Anesthesiologists, and Society of Interventional Radiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23922472" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Risk of sedation for diagnostic esophagogastroduodenoscopy in obstructive sleep apnea patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12135024" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Impairment of psychomotor responses after conscious sedation in cirrhotic patients undergoing therapeutic upper GI endoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10343210" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Risk of sedation for upper GI endoscopy exacerbating subclinical hepatic encephalopathy in patients with cirrhosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24485393" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Guidelines for safety in the gastrointestinal endoscopy unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22624793" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Multisociety sedation curriculum for gastrointestinal endoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17681185" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : AGA Institute review of endoscopic sedation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18708832" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Supplemental oxygen during moderate sedation and the occurrence of clinically significant desaturation during endoscopic procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21680059" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : The utility of high-flow oxygen during emergency department procedural sedation and analgesia with propofol: a randomized, controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16978741" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : The utility of supplemental oxygen during emergency department procedural sedation and analgesia with midazolam and fentanyl: a randomized, controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16573781" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Endoscopic sedation in the United States: results from a nationwide survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18360335" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Sedation for upper endoscopy: comparison of midazolam versus fentanyl plus midazolam.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18360335" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Sedation for upper endoscopy: comparison of midazolam versus fentanyl plus midazolam.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19154568" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Clinical trial: a randomized, study comparing meperidine (pethidine) and fentanyl in adult gastrointestinal endoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16650534" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Pharyngeal anesthesia during sedated EGDs: is "the spray" beneficial? A meta-analysis and systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23678376" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Usefulness of applying lidocaine in esophagogastroduodenoscopy performed under sedation with propofol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22562540" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : The questionable efficacy of topical pharyngeal anesthesia in combination with propofol sedation in gastroscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16377322" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Diphenhydramine as an adjunct to sedation for colonoscopy: a double-blind randomized, placebo-controlled study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29689257" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Use of diphenhydramine as an adjunctive sedative for colonoscopy in patients on chronic opioid therapy: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22579258" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Guidelines for endoscopy in pregnant and lactating women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26688268" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25602023" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25007017" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Sedation for gastrointestinal endoscopy. Clinical practice guidelines of the Sociedad Española de Endoscopia Digestiva.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28714610" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Use of Psychotropic Medications in Breastfeeding Women.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
